AnalystsDavid BuckDavid Buck's Stock Forecasts
AnalystsDavid Buck
Sectors:
Analyst Ranking
Bottom 7%
#4546 out of 4870 analysts
Average Return
-25.35%
Win Rate
29%5 out of 17
Risk vs Reward
Poor
Good
David Buck's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Sucampo Pharmaceuticals IncSCMP | +73.91% | $10.35 | $18.00 | 2017-11-13 - 2017-12-26 | Strong Buy |
Supernus Pharmaceuticals IncSUPN | +23.47% | $36.90 | $45.56 | 2017-11-07 - 2018-11-08 | Strong Buy |
Shire PLCSHPG | +18.39% | $147.82 | $175.01 | 2017-10-18 - 2018-10-19 | Strong Buy |
Supernus Pharmaceuticals IncSUPN | +13.15% | $42.60 | $48.20 | 2017-10-18 - 2018-10-19 | Strong Buy |
Jazz Pharmaceuticals PLCJAZZ | +7.58% | $145.00 | $155.99 | 2017-10-18 - 2018-10-19 | Strong Buy |
David Buck Analyst Color
Get additional color on David Buck's coverage of popular stocks
David Buck's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Spectrum Pharmaceuticals IncSPPI | 3 | Strong Buy | $29.00 | N/A | Maintains | 6 years ago |
Supernus Pharmaceuticals IncSUPN | 3 | Strong Buy | $65.00 | N/A | Maintains | 6 years ago |
Jazz Pharmaceuticals PLCJAZZ | 3 | Strong Buy | $190.00 | N/A | Maintains | 6 years ago |
Amneal Pharmaceuticals IncAMRX | 1 | Strong Buy | $28.00 | N/A | Maintains | 7 years ago |
Endo International PLCENDPQ | 2 | Strong Buy | $15.00 | N/A | Maintains | 7 years ago |
Alkermes PLCALKS | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 7 years ago |
Medicinova IncMNOV | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 7 years ago |
Sucampo Pharmaceuticals IncSCMP | 2 | Hold | N/A | N/A | Downgrades | 7 years ago |
Shire PLCSHPG | 1 | Strong Buy | $201.00 | N/A | Initiates Coverage On | 8 years ago |
Evoke Pharma IncEVOK | 1 | Strong Buy | $1,440.00 | N/A | Reinstates | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.